Institutional investors hold a majority ownership of AMGN through the 81.39% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2017, these large investors purchased a net $785.9 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 12.9 Million shares of Amgen
THE VANGUARD GROUP, INC. Bought 3.6 Million shares of Amgen
BARCLAYS BANK PLC (PRIVATE BANKI... Bought 1.1 Million shares of Amgen